Helen Colhoun

Summary

Affiliation: University College Dublin
Country: Ireland

Publications

  1. ncbi request reprint After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?
    Helen Colhoun
    Conway Institute, University College Dublin, Dublin 4, Ireland
    Lancet 366:1829-31. 2005
  2. ncbi request reprint Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)
    H M Colhoun
    The Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
    Diabetologia 48:2482-5. 2005
  3. ncbi request reprint Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
    Helen M Colhoun
    EURODIAB, Department of Epidemiology and Public Health, Royal Free and University College Medical School, London, UK
    Lancet 364:685-96. 2004
  4. ncbi request reprint Coronary heart disease in women: why the disproportionate risk?
    Helen Colhoun
    The Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
    Curr Diab Rep 6:22-8. 2006
  5. ncbi request reprint Lipid goals in metabolic syndrome and diabetes
    Helen M Colhoun
    The Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
    Curr Atheroscler Rep 9:286-95. 2007
  6. ncbi request reprint C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification
    Helen M Colhoun
    Department of Epidemiology and Public Health, Royal Free and University College London Medical School, London, UK
    Diabetes Care 25:1813-7. 2002
  7. ncbi request reprint Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects
    Helen M Colhoun
    Department of Epidemiology and Public Health, EURODIAB, Royal Free and University College London Medical School, 1 19 Torrington Place, UK
    Atherosclerosis 163:363-9. 2002
  8. ncbi request reprint High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database
    Sabita S Soedamah-Muthu
    Department of Epidemiology and Public Health, Royal Free and University College London Medical School, UK
    Diabetes Care 29:798-804. 2006
  9. ncbi request reprint Problems of reporting genetic associations with complex outcomes
    Helen M Colhoun
    Department of Epidemiology and Public Health, University College London, WC1E 6BT, London, UK
    Lancet 361:865-72. 2003
  10. ncbi request reprint Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)
    H Andrew W Neil
    Division of Public Health and Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK
    Diabetes Care 29:2378-84. 2006

Collaborators

Detail Information

Publications16

  1. ncbi request reprint After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?
    Helen Colhoun
    Conway Institute, University College Dublin, Dublin 4, Ireland
    Lancet 366:1829-31. 2005
  2. ncbi request reprint Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)
    H M Colhoun
    The Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
    Diabetologia 48:2482-5. 2005
    ....
  3. ncbi request reprint Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
    Helen M Colhoun
    EURODIAB, Department of Epidemiology and Public Health, Royal Free and University College Medical School, London, UK
    Lancet 364:685-96. 2004
    ..We aimed to assess the effectiveness of atorvastatin 10 mg daily for primary prevention of major cardiovascular events in patients with type 2 diabetes without high concentrations of LDL-cholesterol...
  4. ncbi request reprint Coronary heart disease in women: why the disproportionate risk?
    Helen Colhoun
    The Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
    Curr Diab Rep 6:22-8. 2006
    ..The practical consequence is that clinicians need to be aware that the usual cardioprotective effect of sex does not apply in diabetic women and that risk factor intervention is needed at an early age...
  5. ncbi request reprint Lipid goals in metabolic syndrome and diabetes
    Helen M Colhoun
    The Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
    Curr Atheroscler Rep 9:286-95. 2007
    ....
  6. ncbi request reprint C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification
    Helen M Colhoun
    Department of Epidemiology and Public Health, Royal Free and University College London Medical School, London, UK
    Diabetes Care 25:1813-7. 2002
    ..In 196 type 1 diabetic subjects and 195 nondiabetic subjects aged 30-55 years, we examined whether C-reactive protein (CRP) is elevated in diabetes and whether CRP is associated with coronary artery calcification (CAC)...
  7. ncbi request reprint Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects
    Helen M Colhoun
    Department of Epidemiology and Public Health, EURODIAB, Royal Free and University College London Medical School, 1 19 Torrington Place, UK
    Atherosclerosis 163:363-9. 2002
    ..Type 1 diabetes is associated with lower levels of FXIIa despite a greater prevalence of atherosclerosis...
  8. ncbi request reprint High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database
    Sabita S Soedamah-Muthu
    Department of Epidemiology and Public Health, Royal Free and University College London Medical School, UK
    Diabetes Care 29:798-804. 2006
    ..To estimate the absolute and relative risk of cardiovascular disease (CVD) in patients with type 1 diabetes in the U.K...
  9. ncbi request reprint Problems of reporting genetic associations with complex outcomes
    Helen M Colhoun
    Department of Epidemiology and Public Health, University College London, WC1E 6BT, London, UK
    Lancet 361:865-72. 2003
    ..Without changes to present practice, we risk wastage of scientific effort and rejection of a potentially useful research strategy...
  10. ncbi request reprint Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)
    H Andrew W Neil
    Division of Public Health and Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK
    Diabetes Care 29:2378-84. 2006
    ..We conducted a post hoc analysis to compare the efficacy and safety of atorvastatin among 1,129 patients aged 65-75 years at randomization with 1,709 younger patients in the Collaborative Atorvastatin Diabetes Study (CARDS)...
  11. doi request reprint The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS)
    Connie B Newman
    Department of Medicine, New York University School of Medicine, VA Hospital, 423 East 23rd Street, Dept of Medicine 11093 South, New York, NY 10010, USA
    Diab Vasc Dis Res 5:177-83. 2008
    ..Overall, these data demonstrate that atorvastatin 10 mg was well tolerated in patients with type 2 diabetes during long-term treatment...
  12. ncbi request reprint Insight into the nature of the CRP-coronary event association using Mendelian randomization
    Juan P Casas
    Centre for Clinical Pharmacology, Department of Medicine, BHF Laboratories at University College London, UCL, London, UK
    Int J Epidemiol 35:922-31. 2006
    ..Since the distribution of this polymorphism occurs at random during gamete formation, its association with coronary events should not be biased or confounded...
  13. ncbi request reprint Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes
    Helen M Colhoun
    Royal Free and University College London Medical School, London, U K
    Diabetes 51:3300-5. 2002
    ..They also support a role for PLTP in the metabolism of apoB-containing lipoproteins...
  14. ncbi request reprint Eicosapentaenoic acid for prevention of major coronary events
    Helen M Colhoun
    Lancet 370:215; author reply 215-6. 2007
  15. ncbi request reprint The big picture on obesity and insulin resistance
    Helen M Colhoun
    J Am Coll Cardiol 40:944-5. 2002
  16. ncbi request reprint Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes
    Helen M Colhoun
    Royal Free and University College London Medical School, London, UK
    Diabetes 51:1949-56. 2002
    ..Type 1 diabetes is associated with differences in NMR-derived particle size, but their pathogenic significance is unclear...